MA Rates Rise for CY2024, Part D Costs to Fall
CMS announced March 31 that Medicare Advantage (MA) plans will receive a 3.32% rate increase for CY2024, as part of CMS’s CY2024 Final Rate Announcement. This is a higher amount than the originally proposed 1.03% increase. A three-year phase in of the risk adjustment policy changes resulted in the additional rate increase.
The announcement also includes changes to Part D policies required by the passage of the Inflation Reduction Act (IRA) of 2022. Beginning in 2024, Part D plan enrollees will spend less money out of pocket for Part D, including no longer paying cost sharing in the Part D coverage gap or catastrophic phase. An expansion of the Low Income Subsidy program provides individuals with incomes between 135-150% of the Federal Poverty Level with $0 Part D premiums and low-cost, fixed copayments for covered prescription drugs. Insulin products will not be subject to the Part D deductible and plans are prohibited from charging more than $35 for a one-month supply of covered insulin products. Part D enrollees can access adult vaccines, recommended by the Advisory Committee on Immunization Practices (ACIP) at no cost and outside their Part D deductible. The final notice also caps Part D base beneficiary premiums at the lessor of 6 % or the amount that would have applied without the IRA.
The CMS Fact Sheet provides further details on the changes CMS is implementing related to risk adjustment and Part D policies.
LeadingAge expects the CY2024 MA policy and technical changes final rule to be issued later this week. The proposed rule contained key changes to MA prior authorization practices.
Most Recommended
September 26, 2024
Hospice CARE Act Introduced; Payment Provision Summary
September 23, 2024
Lourisa Solomon Will Receive the 2024 McHugh Award
September 25, 2024
What McDonald's and Shake Shack Teach Senior Living About Tech and Staffing
October 01, 2024
Nursing Home Staffing Mandates: What You Need to Know
Recently Added
September 30, 2024
Medicare Open Enrollment: Rise in MA Plan Participation Expected
September 30, 2024